In a March 2020 Psychedelic Science Review article, Dr. Alexander Sherwood of the Usona Institute noted that psychedelic research had been impeded by a lack of access to pure, well-characterized research chemicals. The article also covered his addressing this unmet need by publishing synthetic methods for making several psilocybin analogs.1 Dr. Sherwood is the lead author of a recently published…


Previous articleMindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy
Next articlePatent Combining Psychedelics with Cannabinoids Allowed by USPTO